尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Mayer Eldon C. III, 管理人员. Director active across 1 company, notably Eiger BioPharmaceuticals, Inc.. Cumulatively, 4 disclosures have been logged. Split: 0 buy · 3 sells. Total volume traded: €18k. History available since 7 January 2022. The latest transaction was filed on 17 March 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Eldon C. Mayer III is a former Vice President and Chief Commercial Officer at Eiger BioPharmaceuticals, Inc. In this role, he was responsible for the company's commercial strategy and business development. His experience in the biopharmaceutical sector allowed him to lead initiatives aimed at strengthening the company's market position.